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Human brucellosis is a protean disease with a diversity of clinical signs and symptoms resulting from infection with Bru-
cella species. Recent reports suggest a cross-regulation between adrenal steroids (cortisol and dehydroepiandrosterone [DHEA])
and the immune system. Monocytes andmacrophages are the main replication niche for Brucella. Therefore, we investigated the
role of adrenal hormones on the modulation of the immune response mediated by macrophages in B. abortus infection. Cortisol
treatment during B. abortus infection significantly inhibits cytokine, chemokine, and MMP-9 secretion. In contrast, DHEA
treatment had no effect. However, DHEA treatment increases the expression of costimulatory molecules (CD40, CD86), the ad-
hesion molecule CD54, and major histocompatibility complex class I (MHC-I) andMHC-II expression on the surface of B. abor-
tus-infected monocytes. It is known that B. abortus infection inhibits MHC-I andMHC-II expression induced by gamma inter-
feron (IFN-) treatment. DHEA reverses B. abortus downmodulation of the MHC-I and -II expression induced by IFN-. Taken
together, our data indicate that DHEA immune intervention may positively affect monocyte activity during B. abortus infection.
Several years of investigation have revealed a close relationshipbetween the immune and endocrine systems. Substantial evi-
dence supporting the bidirectional communication between the
neuroendocrine and immune systems now exists (1). Immune cell
subsets express receptors for many of the hormones secreted by
the endocrine system, and likewise, receptors for cytokines and
growth factors have been identified on cells of the neuroendocrine
systems (2). Thus, the many lines of communication between the
immune and the endocrine systems could have a profound impact
on immune function, disease development, and susceptibility to
infections (3).
Human brucellosis is characterized by a great diversity of clin-
ical manifestations resulting from infection with Brucella species
(4). It is chiefly an inflammatory disease. Inflammation is present
both in the acute and chronic phases of the disease and in practi-
cally all of the organs affected. Clinical signs of such inflammation
are undulant fever, endocarditis, arthritis, osteomyelitis, menin-
gitis, pleocytosis, cellular infiltration of the joints, orchitis, nephri-
tis, hepatic granuloma, etc. (5).
Brucella abortus infection elicits a vigorous Th1 immune re-
sponse, which also activates cytotoxic T lymphocytes (6–9). De-
spite the recognition that Th1 immunity is crucial for the control
of Brucella infection, several aspects of the immune response, i.e.,
how the innate immune response shapes the adaptive Th1 im-
mune response and why Th1 immunity is not sufficient to com-
pletely eradicate the infection, constitute a conundrum. Macro-
phages/monocytes were recognized to play an important role in
resistance to facultative intracellular bacteria such as Brucella, and
activation of macrophages by specifically committed T lympho-
cytes formed the basis for cell-mediated immunity. However, B.
abortus is endowed with a panoply of survival stratagems to evade
immune responses and survive inside macrophages, creating a
safe niche of replication inside the host (10–13).
Several cytokines that are produced during B. abortus infec-
tion, most of them secreted by macrophages (such as interleu-
kin-1 [IL-1], IL-2, IL-6, IL-8, tumor necrosis factor alpha [TNF-
], and gamma interferon [IFN-]), are known to affect the
release of anterior pituitary hormones by acting on the hypothal-
amus and/or the pituitary gland, resulting in an increase of gluco-
corticoid secretion (14). Glucocorticoids suppress the secretion of
IL-2 (15, 16), which inhibits proliferation of activated Th1 cells.
This phenomenon could also contribute to the persistence and
chronicity of Brucella infection. Recent reports suggest a cross-
regulation between adrenal steroids (glucocorticoids and dehy-
droepiandrosterone [DHEA]) and themodulation of the immune
response (17). The effects ofDHEA are often opposed by the other
important adrenal steroid, cortisol (18). The cortisol/DHEA ratio
is abnormal under various pathological conditions such as AIDS,
rheumatoid arthritis, and tuberculosis (18–20). In previous stud-
ies, significantly higher levels of cortisol in serumwere reported in
patients with acute brucellosis than in brucellosis patients at the
end of antibiotic treatment or than in healthy subjects (21). In
addition, adrenal glands are enlarged in patients with acute bru-
cellosis but return to normal size after therapy (21). Of note, Th1
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responses are preponderant during acute human brucellosis, but
they decline in the chronic phase (12). Thus, it is reasonable to
hypothesize that the neuroendocrine system could modulate im-
mune responses during Brucella infection, particularly influenc-
ing the macrophage response to infection and explaining, at least
in part, the progression of the infection to chronicity.
In this study, we sought to investigate the relevance of the ad-
renal axis in the modulation of monocyte function in the context
of B. abortus infection, a disease in which the induction of an
effective cellular response would be an effective immune response
to eradicate the infection.
MATERIALS AND METHODS
DHEA and cortisol assessment in patients.Human blood was collected
either from healthy male adult individuals (n 23) or from patients with
active acute brucellosis (n 23) fromHospital F.J. Muñiz, Buenos Aires,
Argentina. Patients and control subjects were age and sex matched. Their
ages ranged between 28 and 60 years. The means standard errors of age
were 48.30  10.17 years for control individuals and 46.35  8.95 years
for Brucella-infected patients. Written informed consent was obtained in
accordance with the local Ethics Committee.
Brucellosis was diagnosed on the basis of clinical, serologic, bacterio-
logic, and epidemiologic data. Disease activity was defined by the presence
of typical signs and symptoms (e.g., fever, splenomegaly, lymphadenop-
athy, myalgia, arthralgia, and hepatic involvement). All patients showed
positive results in classic serologic tests, including standard tube aggluti-
nation, 2-mercaptoethanol, Rose bengal, complement fixation, and
Huddleson tests. All patients were classified as having acute disease (du-
ration of illness, 28 to 300 days; median, 60 days). We used the criteria for
discrimination between acute and chronic disease duration as defined by
Young (22).
To assess cortisol andDHEA-S levels in plasma, EDTA-anticoagulated
blood samples were drawn. After centrifugation, plasma aliquots were
preserved at 80°C. Cortisol and DHEA-S were measured by electro-
chemiluminescence tests (automatic analyzer ADVIA CentaurH XP Im-
munoassay System; Siemens Healthcare Diagnostics, Deerfield, IL, USA).
All hormone determinations were performed in the same blood samples,
collected between 8:00 and 8:30 a.m. because of the circadian rhythms.
Bacterial culture. B. abortus S2308 was grown overnight in 10 ml of
tryptic soy broth (Merck, Buenos Aires, Argentina) with constant agita-
tion at 37°C. Bacteria were harvested and the inocula were prepared as
described previously (23). All liveBrucellamanipulations were performed
in biosafety level 3 facilities located at the Instituto de Investigaciones
Biomédicas en Retrovirus y SIDA (Buenos Aires, Argentina).
Cells andmedia.Unless otherwise specified, all experiments were per-
formed at 37°C in a 5% CO2 atmosphere using standard medium com-
posed of RPMI 1640 supplemented with 2 mM L-glutamine, 10% heat-
inactivated fetal bovine serum (FBS) (Gibco-BRL Life Technologies,
Grand Island, NY), 100Uof penicillin perml, and 100g of streptomycin
per ml. THP-1 cells were obtained from the American Type Culture Col-
lection (Manassas, VA) andwere cultured as previously described (24). To
induce maturation, cells were cultured in the presence of 0.05 M 1,25-
dihydroxyvitamin D3 (vitamin D3; Calbiochem-Nova Biochem Interna-
tional, La Jolla, CA) for 48 to 72 h.
Human neutrophils were isolated from venous blood from healthy
human volunteers by a Ficoll-Paque (GE Healthcare, Uppsala, Sweden)
gradient, followed by the sedimentation of erythrocytes in 6% dextran
and hypotonic lysis (25). Neutrophils were harvested, washed twice with
sterile phosphate-buffered saline (PBS), and resuspended at a concentra-
tion of 1  106 cells/ml in RPMI 1640 medium supplemented with 5%
FBS, 1 mM glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin.
Cell viability was 98%, as determined by trypan blue exclusion. The purity
of the final neutrophil preparationwas 95%, as assessed bymorphological
examination after Giemsa staining and flow cytometry light scatter pat-
terns as described previously (26).
Cellular infection. Vitamin D3-treated THP-1 cells, at a concentra-
tion of 1 106 cells/ml, were incubated in round-bottom polypropylene
tubes (Sarstedt,Numbrecht, Germany), infected at differentmultiplicities
of infection (MOI) in the presence or absence of DHEA (1 108M) and
cortisol (1 106 M), and incubated for 1 h at 37°C in a 5% CO2 atmo-
sphere. Cells were extensively washed with RPMI to remove extracellular
bacteria and were incubated in medium supplemented with 100g/ml of
gentamicin and 50 g/ml of streptomycin to kill extracellular bacteria in
the presence or absence of DHEA and cortisol at the indicated concentra-
tions. THP-1 cells and culture supernatants were harvested at 24 or 48 h to
determine cytokine production,matrixmetalloproteinases (MMP) secre-
tion, and major histocompatibility complex class I (MHC-I), MHC-II,
CD54, CD40, andCD86 surface expression. As was required, experiments
were performed in the presence of IFN- (150U/ml; Endogen). Culture of
THP-1with cortisol andDHEA alone resulted in no changes in the above-
mentioned molecules.
To monitor Brucella intracellular survival, cells were lysed with a ster-
ile solution of 0.1% (vol/vol) Triton X-100 in H2O, and serial dilutions of
lysates were rapidly plated on tryptic soy agar plates to enumerate CFU.
Migration assay. Cell migration was evaluated by using 96-well mi-
crochemotaxis plates with 5-m-pore-diameter polycarbonate filters
(Corning, Corning, NY). Neutrophils (106 cells/ml) were placed in the
upper well of the chambers, and the indicated stimuli (culture superna-
tants fromB. abortus-infected THP-1 cells) were placed in the lower wells.
Migration was scored by counting the number of neutrophils that had
reached the bottom well after 2 h. Migration towardN-formyl-L-methio-
nyl-L-leucyl-L-phenylalanine (fMLP, 107 M; Sigma-Aldrich) served as a
positive control. The number of migrating cells was expressed as follows:
chemoattractant index  number of migrating cells to the tested medi-
um/number of migrating cells to fresh culture medium.
Flow cytometry. At the end of culture, cells were washed and incu-
bated with fluorescein isothiocyanate-labeled (FITC) anti-human
HLA-DRmonoclonal antibody (MAb) (clone L243; BD Pharmingen, San
Diego, CA), FITC-labeled anti-human HLA-ABC (clone G46-2.6; BD
Pharmingen), phycoerythrin (PE)-labeled anti-human CD40 (BD Phar-
mingen clone 5C3), PE-labeled anti-humanCD86 [BDPharmingen clone
2331(FUN-1)], PE-labeled anti-human CD54 (BD Pharmingen clone
HA58), or isotype-matched control antibody (Ab) for 30 min on ice. The
cells were thenwashed and analyzedwith a FACScan flow cytometer (Bec-
ton-Dickinson, Franklin Lakes, NJ), using CellQuest software (Becton-
Dickinson). Results were expressed as mean fluorescence intensities
(arithmetic means standard errors of the means).
Zymography.Gelatinase activity was assayed by the method of Hibbs
et al. (27) with modifications, as described previously (23).
Gelatinase activity under native conditions. Gelatinase activity in
unprocessed culture supernatants (native conditions) was measured us-
ing a gelatinase/collagenase fluorometric assay kit (EnzChek; Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. The En-
zChek kit contains DQ gelatin, a fluorescein-conjugated gelatin so heavily
labeled with fluorescein that fluorescence is quenched. When this sub-
strate is digested by gelatinases or collagenases, it yields highly fluorescent
peptides, and the fluorescence increase is proportional to proteolytic ac-
tivity. Collagenase purified from Clostridium histolyticum provided in the
assay kit serves as a control enzyme. Plates were read in a fluorescence
plate reader (Victor3; Perkin-Elmer, Waltham, MA).
Measurement of cytokine concentrations. Secretion of transform-
ing growth factor-	1 (TGF-	1), TNF-, IL-1	, IL-6, IL-8, and mono-
cyte chemotactic protein 1 (MCP-1) in the supernatants was quanti-
fied by enzyme-linked immunosorbent assay (ELISA; BD Biosciences,
San Jose, CA).
Stimulation with recombinant cytokines. As indicated, infections
were performed in the presence of human recombinant IL-6, IL-1	, and
TNF- (R&D Systems) at 50 ng/ml.
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Neutralization of TGF-1. Neutralization experiments were per-
formed with an antibody against human TGF-	1 (IgG, rabbit polyclonal;
Abcam Inc., Cambridge, MA) or its isotype control (rabbit IgG). To per-
form neutralizing experiments, anti-TGF-	1 antibody was included dur-
ing the infection at a final concentration of 20 mg/ml.
mRNA preparation and quantitative PCR. RNA was extracted using
the Quick-RNA MiniPrep kit (Zymo Research), and 1 g of RNA was
subjected to reverse transcription using Improm-II reverse transcriptase
(Promega). PCR analysis was performed with the Mx3000P real-time
PCR detection system (Stratagene) using SYBR green as fluorescent DNA
binding dye. The primer sets used for amplification were as follows:
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) sense, 5=-CGACC
ACTTTGTCAAGCTCA-3=; GAPDH antisense, 5=-TTACTCCTTGGAG
GCCATGT-3=; CIITA (class II transactivator) sense, 5=-CCGACACAGA
CACCATCAAC-3=; CIITA antisense, 5=-TTTTCTGCCCAACTTCTGC
T-3=. The amplification cycles for GADPH and CIITA were 95°C for 30 s,
55°C for 60 s, and 72°C for 60 s. All primer sets yielded a single product of
the correct size. Relative expression levels were normalized against
GADPH.
Statistical analysis. Statistical analysis was performed with one-way
analysis of variance, followed by a post hoc Tukey test, or using the non-
parametric Wilcoxon matched-pair test for paired samples using Graph-
Pad Prism 5.0 software. The data are represented as means  standard
errors of the means (SEM).
RESULTS
DHEA and cortisol in brucellosis patients. Cortisol and DHEA
have opposite effects on immune responses (28), and they are
imbalanced in certain infectious diseases and pathologies (19, 29,
30). Thus, we decided to investigate cortisol and DHEA levels in
patients with acute brucellosis. Cortisol and DHEA concentra-
tions in plasma showedno significant differences betweenpatients
with acute brucellosis and control subjects (Fig. 1A and B). An
increased cortisol-to-DHEA ratio is observed in infectious dis-
eases (19, 29, 30). Further analyses of the cortisol/DHEA ratio
revealed that B. abortus-infected patients had a much higher ratio
than healthy controls (Fig. 1C). These results indicate that the
hypothalamic-pituitary-adrenal (HPA) axis is activated during
Brucella infection.
Cortisol inhibits proinflammatory cytokine and chemokine
production induced by B. abortus infection.Adrenal hormones
participate in the modulation of the function of several im-
mune cells (29). Monocytes/macrophages are the main repli-
cation niche for Brucella and the powerhouse of cytokine produc-
tion (31, 32). Thus, we hypothesized that their function would be
influenced by cortisol andDHEAduring infectionwithB. abortus.
WhenTHP-1monocytes were infectedwithB. abortus in the pres-
ence of cortisol, these cells secreted significantly lower quantities
of proinflammatory cytokines (TNF-, IL-1	, and IL-6) and
chemokines (IL-8 and MCP-1) than did untreated infected cells.
In contrast, treatment with DHEA had no effect on proinflamma-
tory cytokine and chemokine secretion in response to B. abortus
infection. In addition, when the two hormones were administered
together, DHEA did not reverse the inhibitory effect induced by
cortisol treatment on the production of immune mediators (Fig.
2). Although cortisol treatment did not abrogate the production of
IL-8, this reductionwas sufficient to inhibit themigration of neutro-
phils (Fig. 2F). These results indicate that cortisol reduces proinflam-
matory cytokine and chemokine secretion induced by B. abortus in-
fection in monocytes and DHEA cannot reverse this effect.
Adrenal steroids modulate B. abortus intracellular replica-
tion in THP-1 cells. Since cortisol treatment had an effect on
cytokine and chemokine production, experiments were con-
ducted to investigate whether cortisol and DHEA treatment
could modify the capacity of B. abortus to replicate inside THP-1
monocytes. B. abortus replicated in THP-1monocytes in the pres-
ence of cortisol and DHEA at 24 h postinfection. However, corti-
sol significantly (P
 0.01) increased the capacity of B. abortus to
replicate in monocytes with respect to untreated cells. In con-
trast, DHEA did not significantly modify the intracellular B.
abortus replication with respect to untreated cells.When infection
experiments were performed in the presence of both DHEA and
cortisol, there were no differences in intracellular bacterial sur-
vival with respect to untreated cells (Fig. 3A). To determine
whether cortisol treatment affects intracellular replication or in-
creases the bacterial uptake, we determined the number of intra-
cellular bacteria between 2 h and 48 h postinfection. Our results
indicated that at early time points there were no differences in the
number of intracellular bacteria between cortisol-treated and un-
treated cells, indicating that cortisol treatment does not interfere
in bacterial uptake. Yet, differences arise after 24 h, indicating that
cortisol does interfere with bacterial replication (Fig. 3B).
As cortisol and DHEA can be present in any organism before
FIG 1 HPA axis-related hormones. Cortisol (A) and DHEA-S (B) levels in
plasma fromBrucella-infected patients and noninfected patients (control) and
the corresponding cortisol/DHEA-S ratio (C). Bars indicate themeans stan-
dard errors of the means (SEM) for each group. *, P
 0.1.
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Brucella infects the monocytes, experiments were conducted to
determine whether cortisol and DHEA pretreatment could alter
intracellular replication. To this end, THP-1monocytes were pre-
treatedwith cortisol,DHEA, or bothDHEAand cortisol during 24
h and thenwere infectedwithB. abortus. Our results indicated that
hormone pretreatment does not alter intracellular replication
compared with that in untreated cells (not shown).
Adrenal steroids modulate gelatinase secretion induced by
B. abortus infection. We previously demonstrated that THP-1
cells secrete MMP-9 in response to B. abortus infection (23, 33).
Therefore, we investigated the effects of cortisol and DHEA on
MMP-9 secretion upon infection with B. abortus. Cortisol inhib-
ited MMP-9 secretion induced by B. abortus infection, as mea-
sured by zymography. In contrast, DHEA increased MMP-9 se-
cretion. However, when cells were infected in the presence of both
DHEA and cortisol, MMP-9 activity was similar to that produced
by B. abortus-infected cells. These results indicate that cortisol
inhibited B. abortus-induced MMP-9 secretion and DHEA was
able to reverse the inhibitory effect induced by cortisol (Fig. 4A).
MMPs are counterbalanced by the activity of tissue inhibitors,
including TIMPs (tissue inhibitors of metalloproteinases) (33).
Therefore, the net gelatinase or collagenase activity in a complex
sample, such as culture supernatants, depends on the balance be-
tween MMP and TIMP activities. This net activity is not revealed
by zymography, since MMP-TIMP complexes may dissociate
during gel electrophoresis. To assess whether B. abortus infection
in the presence of DHEA and cortisol modified net gelatinase ac-
tivity, culture supernatants from THP-1 monocytes infected with
B. abortus in the presence or not of DHEA and cortisol were incu-
bated with a nonfluorescent gelatin fluorescein conjugate, and the
fluorescence unmasked as a consequence of gelatin degradation
was measured in a fluorometer. Similar results to those deter-
FIG 3 Infection and replication of B. abortus within THP-1 monocytes. After
infection at different MOI in the presence or not of cortisol (1  106 M),
DHEA (1  108 M), or cortisol plus DHEA (1  106 M and 1  108 M,
respectively), cells were incubatedwith antibiotics to kill extracellular bacteria.
Cell lysates obtained at 24 h p.i. were plated onto agar to determine intracel-
lular CFU (A). At 2, 6, 24, and 48 h postinfection, THP-1 cells treated or not
with cortisol were plated on agar to determine intracellular CFU (B). Data are
given as means SEM from at least 4 individual experiments. Significance of
results for treated versus untreated cells: **, P
 0.01; ***, P
 0.001.
FIG 2 Cortisol inhibits proinflammatory cytokine and chemokine production induced by B. abortus infection. (A to E) Cytokine and chemokine production by
THP-1 monocytes infected or not with B. abortus at different MOI treated or not with cortisol (1 106 M), DHEA (1 108 M), or cortisol plus DHEA (1
106 M and 1  108 M, respectively). Levels of TNF- (A), IL-6 (B), IL-1	 (C), IL-8 (D), and MCP-1 (E) were measured at 24 h postinfection (p.i.). (F)
Migration of human neutrophils induced by culture supernatants from Brucella-infected or noninfected (N.I.) THP-1 monocytes treated or not with cortisol
(1  106 M), as measured in a microchemotaxis plate. Supernatants were added pure. Migrated cells were counted at 2 h, and results are expressed as
chemoattractant index (CI) (the number of cells that migrated to conditioned medium divided by the number of cells that migrated to fresh culture medium).
Migration towardN-formyl-L-methionyl-L-leucyl-phenylalanine (fMLP) served as a positive control. Data are given as means SEM from at least 4 individual
experiments. Significance of results for treated versus untreated cells: *, P
 0.1; ***, P
 0.001.
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mined by zymography were obtained when MMP-9 activity was
measured by fluorometry (Fig. 4B), indicating that cortisol and
DHEA canmodulate gelatinase activity instead of modulating the
secretion of TIMPs.
Cortisol inhibition of MMP-9 secretion induced by B. abor-
tus infection is reversed by exogenous TNF- and IL-6. Proin-
flammatory cytokines have been previously involved in MMP
production in different cell types (34–39). To determine whether
TNF-, IL-6, and IL-1	were involved in the downmodulation of
MMP-9 secretion induced by cortisol in B. abortus-infected
monocytes, recombinant cytokineswere added exogenously at the
time of treatment. Recombinant human TNF- and IL-6 reversed
the inhibitory effect onMMP-9 secretion induced by cortisol in B.
abortus-infected monocytes. In contrast, IL-1	 could not reverse
the secretion of MMP-9 downmodulated by cortisol (Fig. 4C).
This indicates that cortisol downmodulates MMP-9 secretion in-
directly, by dampening TNF- and IL-6 production.
DHEA increasesMHC-I andMHC-II expression inB. abortus-
infected monocytes. As already reported (7), B. abortus infection
did not induce changes in expression ofMHC-I andMHC-IImol-
ecules in monocytes/macrophages (Fig. 5). However, cortisol and
DHEA could modulate this expression in the context of bacterial
infections (29, 40, 41). The presence of DHEA during B. abortus
infection induced the expression of MHC-I and MHC-II mole-
cules on THP-1 cells. Cortisol treatment had no effect on the ex-
pression of these molecules when it was added during B. abortus
infection. When infection experiments were performed in the
presence of both cortisol and DHEA simultaneously, we observed
a significant increase of MHC-I andMHC-II expression over that
seen in B. abortus-infected untreated cells or cells treated with
cortisol alone (Fig. 5).
DHEA reverses the effect of cortisol on CD40, CD86, and
CD54 expression in B. abortus-infected monocytes. Costimula-
FIG 4 Adrenal steroids modulate MMP-9 secretion induced by B. abortus
infection.MMP-9 production by THP-1monocytes infectedwithB. abortus at
an MOI of 100 in the presence or not of cortisol (1  106 M), DHEA (1 
108 M), or cortisol plus DHEA (1 106 M and 1 108 M, respectively).
(A) MMP-9 production at 24 h p.i. by B. abortus-infected THP-1 monocytes
was determined in supernatants by zymography. PMA, phorbol myristate ac-
etate. (B) Supernatants were incubated with a fluorescein-conjugated gelatin
substrate (DQ; Invitrogen) that produces highly fluorescent peptides when
gelatin is digested. Data are expressed in fluorescence units indicated by a
fluorometer. (C)MMP-9 production in culture supernatants from B. abortus-
infected THP-1 monocytes (MOI, 100) treated with cortisol (1 106 M) in
the presence or not of recombinant human (rh) TNF-, IL-6, and IL-1	. Data
are given as means SEM from at least 4 individual experiments. Significance
of results for treated versus untreated cells: ***, P
 0.001.
FIG 5 DHEA increases MHC-I and MHC-II expression in B. abortus-infected
monocytes. MHC-I (A) and MHC-II (B) expression by B. abortus-infected
THP-1monocytes (MOI, 100) in the presence or not of cortisol (1 106M),
DHEA (1  108 M), or cortisol plus DHEA (1  106 M and 1  108 M,
respectively). Data are given asmeans SEM fromat least 4 individual experiments.
Significance of results for treated versus untreated cells: *,P
 0.1; **,P
 0.01.
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tory molecules (CD40 and CD86) and the key molecule involved
in cellular recruitment during immune responses, the intercellu-
lar adhesion molecule-1 (CD54), are increased in B. abortus-in-
fected monocytes (42). Cortisol treatment significantly inhibited
the expression of B. abortus-induced CD40, CD86, and CD54.
When infection experiments were performed in the presence of
DHEA, the levels of CD40, CD86, and CD54 were similar to
those observed in untreated B. abortus-infected cells. Interest-
ingly, when infection experiments were performed in the presence
of cortisol and DHEA simultaneously, we observed that CD40,
CD86, andCD54 levels were similar to those induced by untreated
B. abortus-infected cells (Fig. 6). This indicated that in the case of
costimulatory andCD54moleculesDHEA could reverse the effect
of cortisol.
DHEA reverses B. abortus downmodulation of MHC-I and
MHC-II expression inducedby IFN-. IFN-has a critical role in
protective immunity against Brucella (6, 7). The strategies that
allow B. abortus to survive for prolonged periods inside macro-
phages could be explained at least in part by the inhibition of the
IFN--induced expression ofMHC-I andMHC-II molecules (43,
44). We hypothesized that this phenomenon could be modulated
by cortisol and DHEA. Our results indicated that treatment with
DHEA resulted in significant recovery of the inhibited IFN--
induced MHC-I and MHC-II expression mediated by B. abortus
infection. Cortisol had no effect on the downmodulation of IFN-
-inducedMHC-I andMHC-II expression induced by B. abortus.
When the two hormones were administered together, the effect
was similar to that of DHEA alone (Fig. 7). Therefore, DHEA
could reverse the inhibition mediated by B. abortus of IFN--
induced MHC-I and -II expression.
DHEA induces CIITA expression. Transcription of MHC-II
genes depends on a specific non-DNA-binding protein, the class II
transactivator (CIITA) (45). Therefore, experiments were con-
ducted to determine whether the CIITA expression is modulated
by DHEA and cortisol during B. abortus infection in the presence
or not of IFN-. Our results indicated that CIITA expression in-
creased when B. abortus infection was performed in the presence
of DHEA and independent of the presence of IFN- (Fig. 8A and
B, respectively). When the two hormones were administered to-
gether, the effect was similar to that of DHEA alone. Therefore,
CIITA expression can be modulated by DHEA during B. abortus
infection. These results indicate that MHC-II expression can be
modulated by DHEA via regulation of CIITA expression.
TGF-1 contributes to the inhibition of MHC-II expression
induced by IFN- duringB. abortus infection in the presence of
cortisol. Previously, we demonstrated that IL-6 is involved in the
downmodulation of IFN--induced MHC-II in B. abortus infec-
tion (43). The presence of cortisol during B. abortus infection
significantly inhibits IL-6 secretion (Fig. 2B). However, B. abortus
infectionwas able to induceMHC-II downmodulation even in the
presence of cortisol (Fig. 7B). This result indicates that another
mediator is involved in such a phenomenon.
It has been demonstrated in a variety of cell types that TGF-	1
downmodulated MHC-II expression (46, 47). Also, in chronic
Brucella infection patients, it has been demonstrated that circulat-
ing TGF-	1 levels were markedly elevated compared with those
from Brucella-negative healthy subjects; and this upregulation
correlated with diminished lymphoproliferative responses (48).
In infection experiments performed in the presence of cortisol,
we found a significant increase in TGF-	1 secretion (Fig. 9A). In
these assays, THP-1 monocytes were infected with B. abortus in
the presence or absence of neutralizing antibodies to TGF-	1 or
the isotype control. Neutralization of TGF-	1 resulted in signifi-
cant (P 
 0.001) recovery of the inhibition of IFN--induced
MHC-II expressionmediated by B. abortus in the presence of cor-
tisol (Fig. 9B). This result indicates that TGF-	1 is involved in the
FIG 6 DHEA induces CD40, CD86, and CD54 expression on B. abortus-
infected monocytes. CD40 (A), CD86 (B), and CD54 (C) expression by B.
abortus-infected THP-1 monocytes (MOI, 100) in the presence or not of cor-
tisol (1 106 M), DHEA (1 108 M), or cortisol plus DHEA (1 106 M
and 1 108 M, respectively). Data are given as means SEM from at least 4
individual experiments. Significance of results for treated versus untreated
cells: *, P
 0.1; **, P
 0.01.
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inhibition of MHC-II expression induced by IFN- during B.
abortus infection in the presence of cortisol.
DISCUSSION
Host control of brucellosis requires a set of cells and components
of the immune system that together promote a complex response
againstBrucella spp. (49, 50). However, the role of the adrenal axis
in the immune response againstBrucella infection has not yet been
reported.
Under healthy conditions, DHEA secretion is synchronized
with cortisol in response to adrenocorticotropic hormone
(ACTH) and corticotrophin-releasing hormone (CRH), while in
critical illness, a remarkable decrease of DHEA secretion has been
observed (28). The physiological role of DHEA is poorly under-
stood, but there are clear indications that it modulates the im-
mune response and influences both pro- and anti-inflammatory
cytokine release (51–54).
The hypothalamus adrenal axis is activated during many bac-
terial and viral infections, resulting in an increase in circulating
glucocorticoid levels. This activation is dependent on the inflam-
matory cytokines (55, 56). In previous studies, it has been dem-
onstrated that cortisol levels were more elevated in patients with
acute brucellosis than in healthy individuals and patients with
remission (21). In concordance, our results indicated that the cor-
tisol/DHEA ratio in infected patients is much higher than in
healthy controls. This indicated that the hypothalamus adrenal
axis is activated in Brucella-infected patients.
So far, there are no reports describing the effect of adrenal
hormones on monocyte/macrophage function in the context of
Brucella infection. Adrenal hormones participate in the modula-
tion of the function of several immune cells. We hypothesize that
cell function would be influenced by cortisol and DHEA, modu-
lating both innate and adaptive immune responses to B. abortus.
Moreover, the effects of cortisol and DHEA onmonocyte/macro-
phage function have been demonstrated in other infection mod-
FIG 7 DHEA reverses B. abortus downmodulation of MHC-I and II expres-
sion induced by IFN-. B. abortus downmodulates the IFN- induced expres-
sion of MHC-I and MHC-II molecules. THP-1 cells were infected with B.
abortus at an MOI of 100 in the presence of IFN- (150 U/ml) and in the
presence or not of cortisol (1 106M), DHEA (1 108M), or cortisol plus
DHEA (1 106 M and 1 108 M, respectively) for 48 h. MHC-I (A) and
MHC-II (B) expression was assessed by flow cytometry. MFI, mean fluores-
cence intensity. Nonspecific binding was determined using a control isotype
antibody. Data are given as means  SEM from at least 4 individual experi-




FIG8 DHEA induces CIITA expression. CIITA expressionwas determined by
quantitative real-time PCR (qRT-PCR) in THP-1 cells infected with B. abortus
at anMOI of 100 in the presence or not of cortisol (1 106 M), DHEA (1
108M), or cortisol plus DHEA (1 106M and 1 108M, respectively) in
the presence of IFN- (150 U/ml) for 48 h (A) and without IFN- for 24 h (B).
Data are given as means  SEM from at least 4 individual experiments. Sig-
nificance of results for treated versus untreated cells: **, P 
 0.01; ***, P 

0.001.
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els, showing changes in cytokine production, antigen presenta-
tion, and costimulatory molecule expression (57–59).
Cortisol treatment significantly inhibited B. abortus-induced
CD40, CD86, and CD54 expression. Interestingly, when infection
experiments were performed in the presence of cortisol and
DHEA simultaneously, we observed that CD40, CD86, and CD54
levels were similar to those induced by untreated B. abortus-in-
fected cells. Interestingly, the presence of DHEA during B. abortus
infection induces the expression of MHC-I and MHC-II mole-
cules. When infection experiments were performed in the pres-
ence of cortisol and DHEA simultaneously, we also observed a
significant increase of MHC-I and MHC-II. This indicated that
DHEA could positively modulate monocyte function during B.
abortus infection.
IFN- has a critical role in protective immunity against Bru-
cella, and this cytokine enhances both the microbicidal and anti-
gen-presenting functions of macrophages (60–63). In our labora-
tory, we demonstrated that B. abortus infection inhibits MHC-I
and MHC-II expression induced by IFN-, contributing in this
way to the chronicity of Brucella infection (43, 44). Our results
indicated that DHEA immune intervention could positively affect
monocyte function, resulting in a significant recovery of the in-
hibited IFN--inducedMHC-I and -II expression mediated by B.
abortus infection. In addition, DHEA could also reverse the inhi-
bition of IFN--induced MHC-I and -II expression mediated by
B. abortus infection in the presence of cortisol.
TGF-	1 is an important mediator of immune regulation (64),
and its expression is always associated with immune suppression.
In patients with chronic Brucella infection, it has been demon-
strated that circulating TGF-	1 is abundantly secreted in sera and
peripheral blood mononuclear cells (PBMCs) of patients with
chronic brucellosis. The increased activity of TGF-	1 at both
mRNA and protein levels may underlie the depressed function of
T cell responses with consequent prolongation of the disease
course (48). Accordingly, our results indicate that cortisol induces
TGF-	1 secretion by B. abortus-infected monocytes and that this
cytokine is involved in the inhibition ofMHC-II expression as was
demonstrated using specific neutralizing antibodies. In addition,
transcription of MHC-II genes depends on a specific non-DNA-
binding protein, the class II transactivator (CIITA) (45). CIITA
expression can be inhibited by TGF-	1, as was demonstrated in
different cell types (46, 47). In concordance, our results indicate
that cortisol treatment induces TGF-	1 secretion and does not
induce CIITA expression in B. abortus-infected monocytes. In
contrast, DHEA treatment inhibits TGF-	1 secretion with con-
comitant induction of CIITA expression.
Our data demonstrated that DHEA could reverse the effect of
cortisol in the context of Brucella infection, since we observed an
increment of expression of adhesion molecules and molecules in-
volved in antigen presentation andT cell costimulation.However,
DHEA treatment had no effect on proinflammatory cytokine and
chemokine production.
Taken together, our results indicate that DHEA immune inter-
vention may positively affect monocyte function since we ob-
served the induction of a proinflammatory milieu, incremented
expression of the MHC-I and MHC-II molecules and costimula-
tory molecules, and adhesion enhancement.
Finally, the present study constitutes the first analysis on the
immune-endocrine alterations in brucellosis and provides an ini-
tial background for studying in more detail the role of DHEA
during the infection. Thus, the supplementation or cotreatment
withDHEAor derivatives in addition to antibiotics therapy can be
considered as a new possible treatment against Brucella.
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